Bliss GVS Pharma Limited (BOM:506197)
India · Delayed Price · Currency is INR 461.00
-2.55 (-0.55%)
At close: Jul 27, 2026
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 48.89 billion as of July 27, 2026. Its market cap has increased by 202.01% in one year.
Market Cap
48.89B
Enterprise Value
47.61B
Revenue
9.27B
Ranking
n/a
PE Ratio
38.42
Stock Price
461.00
ChartMarket Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 48.89B, an increase of 486,292.91%. That is a compound annual growth rate of 41.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 48.89B | 182.67% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Procter & Gamble Health | 111.61B |
| Viyash Scientific | 109.55B |
| Sanofi India | 78.02B |
| FDC Limited | 66.96B |
| Novartis India | 40.67B |
| Unichem Laboratories | 37.97B |
| Gufic Biosciences | 37.93B |
| Morepen Laboratories | 29.47B |